Madrigal Pharmaceuticals | 8-K: Madrigal Pharmaceuticals Reports Second-Quarter 2024 Financial Results and Provides Corporate Updates
Madrigal Pharmaceuticals | 8-K: Current report
Madrigal Pharmaceuticals | S-3ASR: Automatic shelf registration statement of securities of well-known seasoned issuers
Madrigal Pharmaceuticals | 8-K: Current report
Madrigal Pharmaceuticals | 8-K: Madrigal Pharmaceuticals Reports First-Quarter 2024 Financial Results and Provides Corporate Updates
Madrigal Pharmaceuticals | DEFA14A: Others
Madrigal Pharmaceuticals | DEF 14A: Definitive information statements
Madrigal Pharmaceuticals | 8-K: Current report
Madrigal Pharmaceuticals | 8-K: Current report
Madrigal Pharmaceuticals | 8-K: Current report
Madrigal Pharmaceuticals | 8-K: Current report
Madrigal Pharmaceuticals | 8-K: Madrigal Pharmaceuticals Provides Corporate Updates and Reports Fourth Quarter and Full Year 2023 Financial Results
Madrigal Pharmaceuticals | 8-K: Current report
Madrigal Pharmaceuticals | 8-K: Madrigal Pharmaceuticals Provides Corporate Updates and Reports Third Quarter 2023 Financial Results
Madrigal Pharmaceuticals | 8-K: Current report
Madrigal Pharmaceuticals | 8-K: Current report
Madrigal Pharmaceuticals | 8-K: Current report
Madrigal Pharmaceuticals | 8-K: Current report
Madrigal Pharmaceuticals | 8-K: Current report
Madrigal Pharmaceuticals | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
No Data
No Data